Novel treatment avenues for peripheral T-cell lymphomas

Author： Hopfinger Georg Griessl Robert Sifft Eveline Taylor Ninon Kenner Lukas Greil Richard Merkel Olaf

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.12, 2012-12, pp. : 1149-1163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential of pralatrexate as a treatment of peripheral T-cell lymphoma

By Dondi Alessandra Bari Alessia Pozzi Samantha Ferri Paola Sacchi Stefano

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 711-718

Informa Healthcare

Access to resources Recommend Favorite

A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas

By Kim Seok Kang Hye Kim Jin Eom Hyeon-Seok Huh Jooryung Ko Young Lee Jongtae Yim Dong-Seok Lee Soo-Youn Park Weon Yang Woo Lee Seung-Sook Suh Cheolwon Kim Won

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1514-1521

Springer Publishing Company

Access to resources Recommend Favorite

Impact of comorbidity on survival in peripheral T‐cell lymphomas: A Swedish Lymphoma Registry study

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 159-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Beyond the Guidelines in the Treatment of Peripheral T-Cell Lymphoma: New Drug Development

By Chen Andy I. Advani Ranjana H.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 4, 2008-04 ,pp. : 428-435

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Emerging drugs in cutaneous T-cell lymphomas

By Dummer Reinhard

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 381-392

Informa Healthcare

Access to resources Recommend Favorite